AU1014101A - Use of a phosphotyrosyl phosphatase inhibitor for the treatment of immunosuppressed patients - Google Patents

Use of a phosphotyrosyl phosphatase inhibitor for the treatment of immunosuppressed patients

Info

Publication number
AU1014101A
AU1014101A AU10141/01A AU1014101A AU1014101A AU 1014101 A AU1014101 A AU 1014101A AU 10141/01 A AU10141/01 A AU 10141/01A AU 1014101 A AU1014101 A AU 1014101A AU 1014101 A AU1014101 A AU 1014101A
Authority
AU
Australia
Prior art keywords
treatment
phosphatase inhibitor
immunosuppressed patients
phosphotyrosyl phosphatase
phosphotyrosyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10141/01A
Other languages
English (en)
Inventor
Benoit Barbeau
Jean-Francois Fortin
Michel J. Tremblay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virocell Inc
Original Assignee
Virocell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virocell Inc filed Critical Virocell Inc
Publication of AU1014101A publication Critical patent/AU1014101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU10141/01A 1999-10-26 2000-10-23 Use of a phosphotyrosyl phosphatase inhibitor for the treatment of immunosuppressed patients Abandoned AU1014101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16135499P 1999-10-26 1999-10-26
US60161354 1999-10-26
PCT/CA2000/001258 WO2001030325A2 (fr) 1999-10-26 2000-10-23 Utilisation d'un inhibiteur de la phosphotyrosylphosphatase dans le traitement de patients immunodeprimes

Publications (1)

Publication Number Publication Date
AU1014101A true AU1014101A (en) 2001-05-08

Family

ID=22580857

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10141/01A Abandoned AU1014101A (en) 1999-10-26 2000-10-23 Use of a phosphotyrosyl phosphatase inhibitor for the treatment of immunosuppressed patients

Country Status (4)

Country Link
EP (1) EP1225891A2 (fr)
AU (1) AU1014101A (fr)
CA (1) CA2389348A1 (fr)
WO (1) WO2001030325A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2417627A1 (fr) * 2000-08-02 2002-02-07 Virocell Inc. Procede servant a traiter des maladies infectieuses et/ou a augmenter l'efficacite antimicrobienne de medicaments
US7425537B2 (en) 2000-08-22 2008-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SH2 domain binding inhibitors
US6977241B2 (en) 2000-08-22 2005-12-20 The United States Of America As Represented By The Department Of Health & Human Services SH2 domain binding inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7709687A (en) * 1986-07-03 1988-01-29 Joseph M. Cummins Methods and materials for vanadium immunomodulation
DE4336642C2 (de) * 1993-10-22 1995-08-10 Deutsches Rheuma Forschungszen Verwendung von Vanadiumverbindungen mit antiviraler Wirkung
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
CA2280249A1 (fr) * 1999-08-12 2001-02-12 Universite Laval Composes de vanadium utilises comme facteurs anti-angiogeniques et comme inhibiteurs de production d'endotheline

Also Published As

Publication number Publication date
EP1225891A2 (fr) 2002-07-31
CA2389348A1 (fr) 2001-05-03
WO2001030325A2 (fr) 2001-05-03
WO2001030325A3 (fr) 2002-01-24

Similar Documents

Publication Publication Date Title
AU1877700A (en) Treatment of conditions with a need for the inhibition of gsk-3
AU2492600A (en) Surgical handpiece
AU1224501A (en) Surgical drape
AU2180400A (en) A pharmaceutical combination for the treatment of depression
AU5487800A (en) Fluid treatment system
AU1260401A (en) Thumb splint
AU5619400A (en) Statine-derived tetrapeptide inhibitors of beta-secretase
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
AU2104201A (en) Irrigating forceps
IL146130A0 (en) Anti-inflammatory therapy for inflammatory mideated infection
AU3978700A (en) Medical use
AU1878201A (en) Composition for the treatment of damaged tissue
AU4369000A (en) Inhibition of complement action
AU1014101A (en) Use of a phosphotyrosyl phosphatase inhibitor for the treatment of immunosuppressed patients
AUPP910699A0 (en) Inhibitor of lipoxygenase pathways
AU3760900A (en) Treatment of menstrual function
AU4179497A (en) Use of PKC inhibitors for the manufacture of a medicament for the treatment f AIDS
AU3071799A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection
AU1512501A (en) A negative pressure treatment equipment
AU7740100A (en) Efficient implementation of multiprecision arithmetic
AU1043601A (en) Medical use
AU1405001A (en) Treatment of diseases
AU4980900A (en) Surgical tools
AU3071999A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases
AU7971400A (en) Set of plates for a heat-regenerator

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase